Given the availability of these agents for treating obesity and type 2 diabetes, along with the several agents in development, and current demand, trends in clinical practice have shifted towards personalized and tailored use of these agent for individual patient needs.6 GLP-1 and GIP agonist offer various benefits in managing obesity and type 2 diabetes
Take care and keep well Kind regards Bubba Aww" bubbatetley I'm so sorry to read your sad story
People following keto or low-carb diets often need electrolyte supplementation more than others because the diet causes increased excretion of sodium and potassium
Essentially, it will help with glucose control by helping the pancreas release the correct amount of insulin when carbs are present in the body
In clinical trials, people who could tolerate the maximum dose of the drug 15 milligrams per week lost an average of about 20% of their starting body weight after about a year and a half on the drug
It is a calculated metabolic intervention
![Favourite Worst Nightmare (CD) Back To Black [ International Deluxe Edition ]](https://cdn.shopify.com/s/files/1/0273/8923/1139/products/tws30js1.jpg?v=1678055799)